The following papers are presented

Presenting author: Dr. Luis Paz-Ares PACIFIC: A double-blind, placebo-controlled Phase III study of durvalumab after chemoradiation therapy (CRT) in patients with Stage III, locally advanced, unresectable NSCLC 

More Info

Published also in the NEJM


Presenting author: Prof Dr Virginie Westeel Results of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

More Info

Presenting author: Dr Suresh Ramalingam Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC: FLAURA

More InfoS